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Abstract
Objective: To analyze the production of antibodies to polysaccharide antigens in patients with ataxia-
telangiectasia.
Patients and methods: We used the ELISA technique to measure the levels of IgG antibodies to serotypes 1,
3, 5, 6B, 9V and 14 of Streptococcus pneumoniae in 14 patients with ataxia-telangiectasia before and after
immunization with 23-valent polysaccharide vaccine. Adequate response to individual polysaccharide can be defined
as a postimmunization antibody titer equal to or greater than 1.3 µg/ml or as a minimum fourfold increase over the
baseline (preimmunization) value.
Results: Six (43%) patients showed an absent response to all serotypes analyzed. Four patients showed
adequate response to only one serotype, one patient to two serotypes, two patients to three serotypes and only one
patient to four out of six serotypes analyzed. No patient had adequate response to all serotypes tested.
Postimmunization pneumococcus IgG levels were higher than preimmunization levels to all serotypes analyzed,
except for serotype 3. In spite of this, the mean postimmunization levels were lower than 1.3 µg/ml in all serotypes,
except for serotype 14. Mean increment was less than four in all serotypes analyzed.
Conclusion: Our results suggest that patients with ataxia-telangiectasia are at a high risk of having an impaired
response to pneumococcus, which may be one of the causes of recurrent sinopulmonary infections in these patients.
J Pediatr (Rio J). 2006;82(2):132-6: Ataxia-telangiectasia, Streptococcus pneumoniae, pneumococcus,
polysaccharide, immunodeficiency, humoral immunity, antibody.
Introduction
Ataxia-telangiectasia (AT) is an autosomal recessive
disease that coexists with progressive cerebellar ataxia,
immunodeficiency, sinopulmonary infections, skin
disorders, including telangiectasia, cancer risk,
radiosensitivity and early aging.1,2 It is caused by mutations
of the ATM gene located on chromosome 11q22-23, which
contains 66 exons.3 Patients with AT have an undetectable
intracellular ATM level or absence of catalytic activity.2
Although AT patients are susceptible to recurrent
infections and to immunological disorders (both humoral
and cellular), a specific immunological disorder has not yet
been identified.4,5 Despite normal IgG levels, 80% of AT
patients have IgG2 deficiency; the remaining 20% do not
have a defined pattern.6-8 The production of viral and
bacterial antibodies and antigens may be deficient. The
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Figure 1 - IgA levels in ataxia-telangiectasia patients compared
to the normal values for the Brazilian population10
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immunopathogenic mechanism linking ATM dysfunction,
immunodeficiency, and infection is yet to be established.
The aim of this study was to assess the production of
antibodies to polysaccharide antigens in Brazilian AT
patients after immunization with 23-valent polysaccharide
vaccine.
Patients and methods
Fourteen AT patients (nine males aged between 4 and
17 years) were assessed regardless of whether they had
a clinical history of recurrent infections. All of them were
diagnosed with AT, based on criteria established by the
European Society for Immunodeficiencies (ESID) and by
the Pan-American Group for Immunodeficiency (PAGID).9
Total levels of IgG, IgM and IgA were monitored in all
patients and in seven patients, IgG subclasses (radial
immunodiffusion) were also determined. Results were
compared with age-matched controls.10 The production of
antibodies to protein antigens was evaluated in all patients
for at least two antibodies to vaccine antigens: tetanus,
diphtheria, rubella, or measles.
The production of antibodies to polysaccharide antigens
was analyzed by measuring serum IgG antibodies levels to
pneumococcal serotypes 1, 3, 5, 6B, 9V, and 14 by using
a modified ELISA protocol.11 Serum samples were collected
from the patients before and after immunization with 23-
valent polysaccharide vaccine (Pneumo23fi-Pasteur-
MØrieux). Appropriate immune response to a specific
serotype was defined as the presence of serum IgG levels
equal to or higher than 1.3 µg/ml or as a fourfold increase
over the baseline values.11 The variables were analyzed
by non-parametric Wilcoxon tests, and an alpha equal to
or less than 5% was regarded as statistically significant.
The present study was approved by the local Research
Ethics Committee and an informed consent form was
signed by all parents or surrogates.
Results
All patients initially presented with symptoms of ataxia
in the first two years of life, and 11 (78%) of them had
oculocutaneous telangiectasia at that time. However the
age of diagnosis ranged from 2 to 11 years. Eight (57%)
patients had recurrent sinopulmonary infections, and the
alpha-fetoprotein serum levels ranged from 61.7 to 857
ng/ml (normal: < 5-10 ng/ml).
Serum IgA levels equal to or less than 7 mg/dl were
observed in seven of 14 (50%) patients; IgA levels were
normal in only four (28%) patients (Figure 1). Unlike
IgA levels, serum IgM levels were elevated in 11 (78%),
normal in 2/14 and low in 1/14 patients (Figure 2). IgG
was the immunoglobulin with the highest frequency of
normal levels (78%). Only one patient had IgG levels
below the 3rd percentile for age (Figure 3). As to IgG
subclass levels of seven patients, IgG1 was normal in
all, and IgG3 in six of them. IgG2 level below the 3rd
percentile for age was observed in only one patient, and
IgG4, in three.
Figure 2 - IgM levels in ataxia-telangiectasia patients compared
to the normal values for the Brazilian population10
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The production of antibodies to at least two protein
antigens was normal in all patients.
With regard to the production of antibodies to
polysaccharide antigens, six patients showed no response
to any of the six serotypes analyzed, 4/14 responded to
only one, 1/14 to two, 2/14 to three and only 1/14
showed an appropriate response to four serotypes
(patient who had low IgG2 level). The mean levels of
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Figure 3 - IgG levels in ataxia-telangiectasia patients compared
to the normal values for the Brazilian population10
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antibodies to different serotypes, before and after
immunization, are shown in Table 1. The mean level of
antibodies after immunization was less than 1.3 µg/ml
for all serotypes analyzed, except for serotype 14 (Table
1). By comparing pre and postimmunization levels, we
noted that, except for serotype 3, all other serotypes
had higher post values. Although postimmunization
levels were higher, the mean increment was lower than
four for all serotypes (Table 1). Serotypes with a higher
percentage of positive response in decreasing order
were 5 and 14 (5/14 and 4/14 respectively) followed by
1 and 9B (2/14) and 6 (1/14). None of the patients had
an adequate response to serotypes 3.
Of the six patients who presented absence of  response
to any serotypes, two had normal levels for the three
immunoglobulin classes, three showed low IgA levels with
high IgM titers and one patient had low IgM levels. IgG2
levels, which were normal, were assessed in only two of
these six patients.
Discussion
Ataxia was observed in all patients and telangiectasia
in 11/14 patients before the age of two. However, some
patients were not diagnosed till the age of 11 years
reflecting unawareness of this disease. The earliest
diagnoses occurred in patients with already affected
siblings. Lack of information about the disease resulted in
unnecessary and excessive radiological examinations,
and this is contraindicated in this syndrome due to the
radiosensitivity presented by the patients. None of the
patients were on any type of treatment when they arrived
at our department. All patients were immunized according
to the official immunization schedule, including BCG, and
no side effects were reported. All patients showed high
levels of alpha-fetoprotein, which were the most
characteristic and consistent findings in these patients.12
Lung infections are frequent in AT patients and they
may develop into bronchiectasis and pulmonary fibrosis.
Only eight of our patients had a past history of
sinopulmonary infections. Some patients do not develop
Serotypes Pre Post Mean Pre x post
(Range) (Range) increment (Wilcoxon)
1 0.34 0.57 1.73 p = 0.018
(0.12-0.87) (0.14-1.5)
3 0.29 0.33 0.32 p > 0.05
(0.13-0.49) (0.07-0.95)
5 0.56 0.91 1.67 p = 0.027
(0.15-0.72) (0.07-4.0)
6B 0.32 0.45 1.13 p = 0.027
(0.14-1.58) (0.08-2.3)
9V 0.24 0.48 3.47 p = 0.032
(0.03-0.45) (0.06-1.5)
14 0.48 3.70 3.61 p < 0.05
(0.24-0.85) (0.01-37)
Table 1 - Mean levels of antibodies to pneumococcal serotypes (µg/ml) before and after immunization
with 23-valent polysaccharide vaccine in ataxia-telangiectasia patients (n = 14)
Pre = preimmunization; Post = postimmunization.
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respiratory infections until the later stages of the disease,
and opportunistic infections are extremely rare.2 In addition
to immunodeficiency, aspiration of saliva due to poorly
coordinated swallowing triggered by neurological problems
is an important factor for the development of pneumonia
in these patients.2,4
AT was initially associated with IgA deficiency, observed
in 60 to 70% of patients.6,8 IgA levels less than 7 mg/dl
were detected in 50% of our patients, more often associated
with an increase in IgG and/or IgM levels and with a small
number of CD4 cells (data not shown). Elevated IgM levels
have been observed in AT patients,8 sometimes mimicking
the hyperviscosity syndrome, suggesting a disorder in the
maturation and differentiation of B lymphocytes. The
association between IgA deficiency and unresponsiveness
to polysaccharide antigens has been described.13 Of
seven patients with IgA less than 7 mg/dl, three did not
respond to the pneumococcal vaccine, two showed an
appropriate response to one serotype, one of them to
three serotypes and another one to four serotypes. The
latter patient was the one who had the best response after
immunization.
Normal IgG levels have been observed in AT
patients,5,6,8 in agreement with our findings. Controversial
results have been described for IgG subclasses in these
patients.6-8 However, IgG2 in subnormal concentration
does not necessarily reflect immunodeficiency.14 Stray-
Pedersen et al. found a positive relationship between
antibody levels to pneumococcus and IgG2.1 We could not
find this relationship in our patients, since only two
unresponsive patients had their IgG2 levels assessed and
were normal. The only patient with low IgG2 levels was the
one who showed an appropriate response to the largest
number of serotypes.
Polysaccharide antigens are referred to as thymus-
independent and complement receptors in B cells (BCR)
appear to be of crucial importance in the response to such
antigens.15,16 All analyzed patients showed normal levels
of total hemolytic complement (CH50) (data not shown).
In humans, IgG2 is the prevailing antibody class
induced by pneumococcal capsular polysaccharides.17
Pneumococcal immunization and evaluation of the result
of the IgG class antibody response to pneumococcal
polysaccharide serotypes included in the vaccine are an
accepted method to identify deficiencies in the development
of antibodies against polysaccharide antigens.11 In this
study, we included the serotypes that largely account for
pneumococcal invasive disease in Brazil18 and we noted
that serotypes 5 and 14 turned out to be the most
immunogenic in this group of patients. Response intensity
increases significantly with age, and is negligible or absent
in the first two years of life.11 As all of our patients were
over 4 years old at the time of immunization, we can rule
out immaturity of the immune system as causing an
inadequate response. Recently, Sanal et al. have reported
absence of polysaccharide response in 22/31 AT patients.
Of the remaining nine, five patients responded to only one
serotype, one patient to two serotypes, and three patients
to more than three serotypes.19 Those authors did not find
any correlation between the production of these antibodies
and the presence or absence of intracellular ATM protein.
All patients, but one, presented with homozygous truncating
mutations  and there was no correlation between this
distal or proximal mutation with pneumococcus antibody
levels.19 These patients did not show an appropriate
response even after immunization with the conjugate
vaccine.20 Inappropriate response to pneumococcus and
to Haemophilus influenzae type b after immunization has
also been described by other authors.1 Inadequate response
to polysaccharide antigens is frequent amongst these
patients and occurs regardless of the presence of recurrent
infections. Also important is the fact that our patients have
different types of mutation,21 which means that impaired
production of antibodies to polysaccharide antigens does
not seem to be related to these mutations.
The ability of B lymphocytes to express surface
immunoglobulins with identical antigen specificity, but
with different effector functions, results from the cells
capacity to undergo class switch recombination (CSR).
The ATM protein may be required for the signal transduction
in B lymphocytes.1 A-T cells are defective in signaling
through the B cell receptor (BCR), with a likely involvement
of tyrosine kinase dysfunction.22
Our results suggest that AT patients are at a greater
risk of showing impaired response to pneumococcus,
which may be one of the causes of recurrent sinopulmonary
infections. Early treatment must be initiated when such an
infection is suspected.
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